March 25th 2025
Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.
March 24th 2025
March 20th 2025
March 19th 2025
March 10th 2025
March 7th 2025
March 6th 2025
March 5th 2025
March 3rd 2025
February 23rd 2025
February 22nd 2025
February 1st 2025